IIRM Holdings India Ltd Reports Audited FY26 Financials
IIRM Holdings India Limited announced its audited standalone and consolidated financial results for the fiscal year ending March 31, 2026. The company reported a consolidated net profit of ₹24.37 crore on revenue of ₹252.15 crore for the full year.
Reader Takeaway: Strong consolidated profits driven by subsidiaries, but standalone losses persist; subsidiary to fund growth.
What just happened
IIRM Holdings India Limited disclosed its audited financial results for the fiscal year ended March 31, 2026. Key figures include consolidated revenue of ₹252.15 crore and a consolidated net profit of ₹24.37 crore. The company also announced significant corporate actions, including the appointment of M/s. B Venkata Chandu and Associates as internal auditor and Ms. Vempala Sri Lakshmi as Company Secretary.
Why this matters
The results provide investors with a clear view of the company's financial performance for the fiscal year. The consolidated profit indicates overall group health, while the subsidiary's fundraising plan signals potential for expansion and operational strengthening in its core businesses.
The backstory
This filing covers the financial year 2025-26. The company operates across insurance broking and risk management services. The financial performance reported reflects the operational activities and market conditions during this period.
What changes now
Following these results, investors can assess the company's performance trajectory. The subsidiary's planned NCD issuance of up to ₹65 crore will inject capital, which is crucial for its operational expansion and strategic initiatives. The appointments of a new internal auditor and company secretary are routine governance enhancements.
Risks to watch
A key concern is the standalone entity's performance, which reported a net loss of ₹0.05 crore for the March 2026 quarter. This highlights a reliance on subsidiaries for overall profitability and warrants attention from investors regarding the standalone business's health.
Context metrics (time-bound)
- Consolidated Revenue (FY26): ₹252.15 crore
- Consolidated Net Profit (FY26): ₹24.37 crore
- Standalone Revenue (FY26): ₹5.29 crore
- Standalone Net Profit (FY26): ₹0.94 crore
- Consolidated Revenue (Q4 FY26): ₹64.01 crore
- Consolidated Net Profit (Q4 FY26): ₹6.77 crore
- Subsidiary NCD Issuance: Up to ₹65 crore
What to track next
Investors should monitor the deployment of the ₹65 crore raised by the subsidiary and assess its impact on business growth. Additionally, tracking the improvement in the standalone entity's financial performance will be critical for a holistic view of the company's prospects.
